UHS is the ticker symbol for UNIVERSAL HEALTH SERVICES INC, a publicly traded Healthcare sector company listed on NYSE. 13F Pro tracks UHS with AI-powered analysis, a 32-signal quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is UHS a good stock to buy?

13F Pro's AI ranking engine scores UHS at 66.7/100, ranked #405 of 2,960 stocks based on 32 fundamental signals including profitability, growth, balance sheet strength, and free cash flow. The full AI verdict and bull/bear case for UHS is available at https://13fpro.ai/company/UHS. Not investment advice — review the underlying SEC filings before making any trade.

Where does 13F Pro source UHS data?

All UNIVERSAL HEALTH SERVICES INC fundamentals and ownership data come directly from SEC EDGAR. UNIVERSAL HEALTH SERVICES INC files with the SEC under CIK 352915. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

UNIVERSAL HEALTH SERVICES INC(UHS)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

UNIVERSAL HEALTH SERVICES INC (UHS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores UHS at 66.7/100 on a 32-signal composite quality model, placing it at rank #405 of 2,960 stocks — the top 25% of the AI-ranked universe. UHS scores in the top quartile across revenue scale (91.8), balance sheet strength (85.2). Based on the latest XBRL financial filings (Q2 2026), UNIVERSAL HEALTH SERVICES INC reports quarterly revenue of $4.6B, net income of $358.4M, an operating margin of 11.1%. Top institutional holders of UHS by reported 13-F value include First Eagle Investment Management, BlackRock, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. UHS trades on the NYSE exchange and files with the SEC under CIK 352915. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate UHS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for UNIVERSAL HEALTH SERVICES INC directly from SEC EDGAR.

AI Quality Score

66.7/100

AI Rank

#405

Revenue

$4.6B

Net Income

$358.4M

Free Cash Flow

$215.7M

Operating Margin

11.1%

UHS key financials by period

UNIVERSAL HEALTH SERVICES INC reported revenue, net income and margins by fiscal period, from SEC filings.
Period	Form	Revenue	Net income	Operating margin
FY 2025	10-K	$17.4B	$1.5B	11.5%
FY 2024	10-K	$15.8B	$1.1B	10.6%
FY 2023	10-K	$14.3B	$717.8M	8.2%
FY 2022	10-K	$13.4B	$675.6M	7.5%
FY 2021	10-K	$12.6B	$991.6M	10.8%
FY 2020	10-K	$11.6B	$944.0M	11.8%

Institutions holding UHS

Institutional investors reporting a position in UNIVERSAL HEALTH SERVICES INC on SEC Form 13F.
Institution	Shares	Value	Reported
First Eagle Investment Management	4,554,670	$677.2M	2026-06-30
BlackRock	4,059,826	$603.7M	2026-06-30
VANGUARD CAPITAL MANAGEMENT	3,392,199	$504.4M	2026-06-30
VANGUARD PORTFOLIO MANAGEMENT	2,452,177	$364.6M	2026-06-30
DIMENSIONAL FUND ADVISORS	2,210,595	$328.7M	2026-06-30
STATE STREET	2,102,613	$312.6M	2026-06-30
GEODE CAPITAL MANAGEMENT	1,974,065	$293.2M	2026-06-30
PZENA INVESTMENT MANAGEMENT	1,969,327	$292.8M	2026-06-30
Invesco Ltd.	1,951,147	$290.1M	2026-06-30
FMR	1,416,755	$210.7M	2026-06-30

SEC EDGAR: CIK 352915 →

UNIVERSAL HEALTH SERVICES INC

UHS

NYSELarge CapHealthcare

13F Pro Quality Score

66.7/100

Rank #405 of 2,960 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

60.6/100

Profitability

60.9/100

Balance Sheet

85.2/100

Earnings Quality

65.0/100

Free Cash Flow

41.2/100

Institutional Flow

56.7/100

Revenue Scale

91.8/100

Dilution Risk

72.9/100

Price Chart

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

What's Driving UHS's Business? Latest 10-Q Breakdown

AI-extracted from the 10-Q filed 2026-08-07 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Biggest Revenue Drivers

Acute Care Hospital Services$2.610B+8.6% YoY

8.2% Same Facility revenue growth plus higher provider tax assessments

Behavioral Health Care Services$2.025B+7.9% YoY

7.4% Same Facility growth and higher provider tax assessments, partly offset by lower revenue at Laurel Ridge

Biggest Revenue Drivers

Total revenue: $4.638B+8.3% YoY

Acute Care Hospital Services$2.610B+8.6% YoY

8.2% Same Facility revenue growth plus higher provider tax assessments

Behavioral Health Care Services$2.025B+7.9% YoY

7.4% Same Facility growth and higher provider tax assessments, partly offset by lower revenue at Laurel Ridge

Within Behavioral Health Care Services

UK Revenue$269M+9% YoY

Behavioral health facilities located in the U.K.

Largest Expense Items

Salaries, wages and benefits$2.140B+6.2% YoY

Increased patient volumes and wage inflation

Supplies expense$423M+1.1% YoY

Depreciation and amortization$167M+10.1% YoY

Newly opened facilities including Alan B. Miller Medical Center

Margins: Income from operations fell to 11.1% of net revenues from 11.7% a year ago; salaries as a % of revenue improved but other operating expenses rose to 29.1% of revenue from 27.1% due to provider tax assessments, physician cost growth, and a $28M self-insured liability reserve increase.

Watch Items from the Filing

Cumberland Hospital litigation: jury awarded $60M compensatory, $180M trebled, and $120M punitive damages against subsidiaries; ~43 additional plaintiffs pending and remaining 2020-policy-year insurance coverage is only ~$143M.
OBBBA legislation is estimated to reduce UHS's aggregate annual net benefit from state Medicaid supplemental payment programs by approximately $500 million by 2032, starting with 2028 state fiscal years.
$28 million pre-tax increase to professional and general liability reserves recorded in Q2 2026 due to unfavorable claims trends; total self-insured P&GL accrual reached $499M.
Laurel Ridge Treatment Center (330 beds, ~$23M 2025 pre-tax income) was terminated from Medicare/Medicaid in April 2026, and Provo Canyon School's Utah facilities had licenses revoked in July 2026, forcing patient discharges.
Pending ~$835 million acquisition of Talkspace, Inc., expected to close Q3 2026, financed via additional credit facility borrowings.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →